SCHEMBL25880182

SCHEMBL25880182

c1ccc(-c2cccc(N(c3ccc4c(ccc5sc6ccccc6c54)c3)c3ccc4ccc5ccccc5c4c3)c2)cc1

nearest known ligand 0.34

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CYP1B1 Q16678 3/20 0.34
▸ CYP1A1 P04798 2/20 0.34
▸ NQO1 P15559 1/20 0.34
▸ NQO2 P16083 1/20 0.34
▸ ALDH1A1 P00352 2/20 0.33
▸ HSD17B10 Q99714 2/20 0.33
▸ HIF1A Q16665 1/20 0.33
▸ CYP1A2 P05177 3/20 0.32
▸ ERBB2 P04626 1/20 0.32
▸ FYN P06241 1/20 0.32
▸ MAOA P21397 1/20 0.32
▸ ACHE P22303 1/20 0.32
▸ AHR P35869 1/20 0.32
▸ F9 P00740 3/20 0.32
▸ HPGD P15428 1/20 0.31
▸ CDK4 P11802 2/20 0.30
▸ CCND1 P24385 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25880183 0.98 CYP1B1 (0.35) CYP1B1CYP1A1NQO1NQO2ALDH1A1
SCHEMBL25879321 0.97 CYP1B1 (0.34) CYP1B1CYP1A1NQO1NQO2ALDH1A1
SCHEMBL25880178 0.96 F9 (0.35) CYP1B1CYP1A1NQO1NQO2ALDH1A1
SCHEMBL24657228 0.94 CYP1A1 (0.33) CYP1B1CYP1A1NQO1NQO2CYP1A2
SCHEMBL24657197 0.94 CYP1A1 (0.33) CYP1B1CYP1A1NQO1NQO2CYP1A2
SCHEMBL25880179 0.94 F9 (0.36) CYP1B1CYP1A1NQO1NQO2CYP1A2
SCHEMBL24657223 0.94 CYP1A1 (0.34) CYP1B1CYP1A1NQO1NQO2CYP1A2
SCHEMBL25880171 0.93 NQO2 (0.35) CYP1B1CYP1A1NQO1NQO2ALDH1A1
SCHEMBL25880065 0.93 CYP1A1 (0.33) CYP1B1CYP1A1NQO1NQO2ALDH1A1
SCHEMBL25882080 0.93 CYP1A1 (0.35) CYP1B1CYP1A1NQO1NQO2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023132694-A1 ORGANIC LIGHT-EMITTING DEVICE 주식회사 엘지화학 2023-07-13 — — WO disclosed
Send feedback